// App-Quantinova.ai

: A New Treatment for Thrombosis Prevention?

Researchers

Presenter

  • B. Dahlf

Principal Investigators

  • P. Larsson

  • J.-P. Idstrm

  • N. Bergh

Medical Centers

  • Gothenburg University, Sahlgrenska Academy, Institute of Medicine, Department of Molecular and Clinical Medicine, Gothenburg, Sweden

  • Cereno Scientific, Gothenburg, Sweden

  • Monash University, Australian Centre for Blood Diseases, Melbourne, Australia

Locations

  • Sweden

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • Collagen type IV alpha 2 chain

  • Serpin E1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • Cereno Scientific

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved